IF a single intramuscular injection of AAV9 encoding full-length murine IL-33 (AAV9-CMV/CK8-mIL33, target dose 1×10¹¹ vg/limb) is administered to the tibialis anterior and gastrocnemius of aged (24-month-old) male C57BL/6J mice with established sarcopenia,
THEN a ≥30% expansion of Pax7⁺ satellite cells per myofiber cross-section, ≥15% increase in myofiber cross-sectional area (CSA), and ≥20% improvement in ex vivo tetanic force will be observed at 12 weeks post-injection versus AAV9-GFP controls,
BECAUSE the following causal chain operates:
-
In aged skeletal muscle, fibro-adipogenic progenitors (FAPs) — the dominant Pdgfrβ⁺ stromal cell population of the muscle interstitial niche — upregulate Pdgfrβ signaling with age, which, by direct analogy to the aged subcutaneous adipose stromal vascular compartment, suppresses endogenous IL-33 mRNA transcription and protein secretion into the niche microenvironment (Pdgfrβ deletion in aged adipose SV cells restored IL-33 mRNA and protein secretion, and rescued type 2 effector signaling in aged mice) (Reversing Pdgfrβ Signaling)[https://doi.org/10.1101/2024.06.17.599436] [SPECULATIVE — cross-tissue extrapolation; FAP-specific IL-33 suppression in muscle not yet directly demonstrated]
-
The resulting IL-33 deficiency in the aged muscle niche starves satellite cells of the ST2-activating alarmin signal required to exit quiescence and initiate symmetric expansion; AAV9-driven transgenic IL-33 restores physiologic alarmin concentration in the interstitium, bypassing FAP-mediated suppression **[SPECULATIVE — mechanistic link betw





























